ST Premium
For just $1, you can unlock ST Grading’s top-rated stocks that consistently beat the market. Our AI-powered Smart Screener finds winning trades in seconds, helping you uncover hidden opportunities before others do.
Ready to Win Big?
Try Now for Just $1!SLRN Company Profile and Key Details
Acelyrin, Inc.
SLRN Stock Price Chart
Stock Price Today
Acelyrin, Inc. (SLRN) stock surged +19.82%, trading at $2.60 on NASDAQ, up from the previous close of $2.17. The stock opened at $2.55, fluctuating between $2.37 and $2.64 in the recent session.
Stock Snapshot
Stock Price History Chart
Contact Details
About Company
Acelyrin, Inc., a clinical biopharma company, focuses on identifying, acquiring, and accelerating the development and commercialization of transformative medicines. The company's lead product candidate is izokibep, a small protein therapeutic designed to inhibit IL-17A with high potency, which is in Phase 3 clinical trials for use in the treatment of Hidradenitis Suppurativa, Psoriatic Arthritis, and uveitis, as well as in Phase 2 clinical trials for use in the treatment of Axial Spondyloarthritis. It is also developing lonigutamab, a humanized immunoglobulin G1 (IgG1) monoclonal antibody against insulin-like growth factor 1 receptor, which is in Phase 1 clinical trials for use in the treatment of thyroid eye disease; and SLRN-517, a fully human IgG1 monoclonal antibody targeting c-KIT, which is in preclinical stage for use in the treatment of chronic urticaria. The company was incorporated in 2020 and is headquartered in Agoura Hills, California.
Company Information
| Employees | 135 |
| Beta | 1.87 |
| Sales or Revenue | N/A |
| 5Y Sales Change% | 0% |
| Fiscal Year Ends | N/A |
| Sector | Healthcare |
| Industry | Biotechnology |
Frequently Asked Questions
Acelyrin, Inc. (NASDAQ: SLRN) stock price is $2.60 in the last trading session. During the trading session, SLRN stock reached the peak price of $2.64 while $2.37 was the lowest point it dropped to. The percentage change in SLRN stock occurred in the recent session was 19.82% while the dollar amount for the price change in SLRN stock was $0.43.
The NASDAQ listed SLRN is part of Biotechnology industry that operates in the broader Healthcare sector. Acelyrin, Inc. designs, manufactures, and markets smartphones, personal computers, tablets, wearables, and accessories worldwide.
No Data
SLRN's closing price is 40.92% higher than its 52-week low of $1.85 where as its distance from 52-week high of $8.89 is -70.74%.
Number of SLRN employees currently stands at 135.
Official Website of SLRN is: https://www.acelyrin.com
SLRN could be contacted at phone 805 730 0360 and can also be accessed through its website. SLRN operates from 4149 Liberty Canyon Road, Agoura Hills, CA 91301, United States.
SLRN stock volume for the day was 12.54M shares. The average number of SLRN shares traded daily for last 3 months was 1.91M.
The market value of SLRN currently stands at $260.85M with its latest stock price at $2.60 and 100.33M of its shares outstanding.
Stocks Telegraph provides information and tools designed to assist investors and Wall Street players. A major goal is to offer financiers comprehensive information that will help them gain insight into investing.
© 2025 Stocks Telegraph All rights reserved.
Most stock quote data provided by financialmodelingprep.com